President and Chief Executive Officer, Terumo BCT and Chair, Global Blood Management Business, Terumo Corporation, Board Member and Committee Member, AdvaMed
David Perez is president and CEO of Terumo BCT, a nearly $1 billion, mission-driven biomedical company focused on unlocking the potential of blood and cell-based therapies. The innovative medical device company strives to advance patient care, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine. Leading Terumo BCT for nearly two decades, Perez is known for his engaging management style focused on results and relationships. His relentless attention to business fundamentals and operational excellence enables the company to grow, innovate and diversify.
1 blog from the author
Posted on 02.05.2018
This blog is part of the GMTCC 2018 blog series. You can follow the conversation under #GMTCC and find more details and at gmtcc.com. Check out related blogs: Swifter, Higher, Stronger: Promoting MedTech Ethics on the Global Stage, Global Responsibility, Global Ethics and Compliance, Global Principles for MedTech Innovation, Progress and new challenges after 10 years of collaboration, Distributors […]